Hipragumboro CW lyoph. for drinking water

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Infectious Bursal Disease Virus (live)

Disponibbli minn:

Laboratorios Hipra S.A.

Kodiċi ATC:

QI01AD09

INN (Isem Internazzjonali):

Gumboro Virus (IBDV)

Għamla farmaċewtika:

Lyophilisate for use in drinking water

Kompożizzjoni:

Gumboro Virus (IBDV)

Rotta amministrattiva:

Oral use

Grupp terapewtiku:

poultry

Żona terapewtika:

Avian Infectious Bursal Disease Virus (Gumboro Disease)

Sommarju tal-prodott:

CTI code: 395333-04 - Pack size: 10 x 1000 doses - Commercialisation status: NO - CNK code: 2937357 - Delivery mode: Medical prescription; CTI code: 395333-03 - Pack size: 10000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 395333-06 - Pack size: 10 x 10000 doses - Commercialisation status: YES - CNK code: 2937332 - Delivery mode: Medical prescription; CTI code: 395333-05 - Pack size: 10 x 5000 doses - Commercialisation status: YES - CNK code: 2937340 - Delivery mode: Medical prescription; CTI code: 395333-02 - Pack size: 5000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 395333-01 - Pack size: 1000 doses - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2011-07-05